Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Schlenk, RF; Frohling, S; Hartmann, F; Fischer, JT; Glasmacher, A; del Valle, F; Grimminger, W; Gotze, K; Waterhouse, C; Schoch, R; Pralle, H; Mergenthaler, HG; Hensel, M; Koller, E; Kirchen, H; Preiss, J; Salwender, H; Biedermann, HG; Kremers, S; Griesinger, F; Benner, A; Addamo, B; Dohner, K; Haas, R; Döhner, Hartmut; AML Study Grp Ulm

Erstveröffentlichung

2004

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Schlenk, RF

Frohling, S

Hartmann, F

Fischer, JT

Glasmacher, A

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

Leukemia ; 18 (2004), 11. - S. 1798-1803. - ISSN 0887-6924

Link to publication

https://dx.doi.org/10.1038/sj.leu.2403528

Keywords

all-trans retinoic acid; acute myeloid leukemia; elderly patients; colony-stimulating factor; acute myelogenous leukemia; southwest-oncology-group; council aml11 trial; cytosine-arabinoside; elderly-patients; bcl-2; chemotherapy; expression; idarubicin

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record